Treatment of Oral Streptococcal Infections

First-Line Treatment Options for Oral Strep Infections

The American Academy of Family Physicians recommends penicillin V as the treatment of choice for uncomplicated group A streptococcal pharyngitis due to its proven efficacy, safety, narrow spectrum, and low cost 3
For children, amoxicillin 50 mg/kg once daily (maximum 1000 mg) for 10 days is often preferred over penicillin V due to better taste acceptance with equal efficacy 2, 3
For adults, penicillin V 250 mg four times daily or 500 mg twice daily for 10 days is the standard recommendation 2, 3
The American Academy of Family Physicians recommends intramuscular benzathine penicillin G for patients unlikely to complete a full 10-day course of oral therapy 2, 3

The American Academy of Family Physicians specifically recommends Augmentin for chronic streptococcal carriers at a dosage of 40 mg amoxicillin per kg per day in three doses (maximum = 2,000 mg amoxicillin per day) for 10 days, with a strong, moderate-quality evidence rating 1, 2
Augmentin has not been shown to provide additional benefit over penicillin or amoxicillin for uncomplicated streptococcal pharyngitis in patients without beta-lactamase producing co-pathogens 2, 3

For patients with penicillin allergy, the American Academy of Family Physicians recommends first-line alternatives, including cephalexin 20 mg/kg per dose twice daily (maximum = 500 mg per dose) for 10 days (for non-immediate hypersensitivity) 2
Clindamycin 7 mg/kg per dose three times daily (maximum = 300 mg per dose) for 10 days is also recommended for penicillin-allergic patients 2
Azithromycin 12 mg/kg once daily (maximum = 500 mg) for 5 days is an alternative for penicillin-allergic patients 1, 4

The standard duration for most oral antibiotics is 10 days to achieve maximal pharyngeal eradication of group A streptococci, according to the American Academy of Pediatrics and the Infectious Diseases Society of America 3, 5
Routine post-treatment throat cultures are not recommended for asymptomatic patients who have completed therapy, as stated by the Infectious Diseases Society of America 3, 5

The American Academy of Pediatrics recommends avoiding the use of broad-spectrum antibiotics like Augmentin as first-line therapy when narrower spectrum options (penicillin or amoxicillin) would be effective 6, 3
Inadequate treatment duration can lead to complications such as rheumatic fever; the full recommended course must be completed, as emphasized by the American Academy of Family Physicians and the American Academy of Pediatrics 3
Failing to consider local resistance patterns when selecting therapy is a common pitfall, according to the American Academy of Family Physicians and the Infectious Diseases Society of America 2, 4